CClinicalTrials.gg
CompletedNCT01607437HowellUpdated May 30, 2012

Clinical Follow-up After ACL Reconstruction

An observational study in Deficiency of Anterior Cruciate Ligament and Injury of Anterior Cruciate Ligament, sponsored by Bergen Knee Group. Completed at 1 site in Norway. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2012-05-30.

Sponsored by Bergen Knee Group · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
96
Ages
16 Years to 50 Years
Sex
All
01

Study summary

No former studies have done long-term evaluation on patients reconstructed with hamstrings graft, the use of Howells tibial guide and transtibial drilling of the femoral graft tunnel. The investigators aim to evaluate clinical, radiographic and subjective outcome at a minimum of 10 years after surgery. According to former published studies on alike methods, the use of transtibial drilling of the femoral graft tunnel causes an increased rotational instability of the knee. The investigators aim to map the clinical stability of this group as well as evaluating the general outcome at the long-time horizon.

Read the detailed description

Patients will be invited to a clinical follow-up with x-ray of the knee, scoring of Lysholm and IKDC subjective scores, clinical examination including instrumented testing with a KT-1000. After informed consent data will be collected from patient records and stored in a secured internal database. Analysis will be done with the SPSS package.

02

Conditions studied

  • Deficiency of Anterior Cruciate Ligament
  • Injury of Anterior Cruciate Ligament
03

In context

Anterior Cruciate Ligament Injuries

512 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 163 are open to participants now.

This study's enrollment of 96 is close to the median of 92 across 127 observational studies indexed under Anterior Cruciate Ligament Injuries.

Browse Anterior Cruciate Ligament Injuries studies →

Lead sponsor

This is the only study on the registry with Bergen Knee Group as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients reconstructed with Howells guide, hamstrings graft and transtibial drilling at Haraldsplass Deaconess Hospital from 1999 to 2001.

Inclusion criteria

  • Patients reconstructed with the given technique

Exclusion criteria

Exclusion Criteria:

  • Patients reconstructed with other techniques
  • Concomitant ligamental surgery
  • Bilateral ACL injury
  • Revision surgery
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
96 participants (actual)
06

What researchers measure

Primary outcomes

  1. Revision surgery

    When patients have had a new ACL reconstruction of the ACL

    Time frame: 10 years

07

Study locations

1 site
  • Haraldsplass Deaconess Hospital
    Bergen, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01607437
Lead sponsor
Bergen Knee Group
Responsible party
Eivind Inderhaug (Medical Doctor, Bergen Knee Group) — Principal investigator
First posted
May 30, 2012
Start date
Feb 2011
Primary completion
Feb 2012
Completion
Feb 2012
Last update
May 30, 2012

Study contacts

Eivind Inderhaug, MD
principal investigator · Bergen Knee Group

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion